ArticleCardiovascular research2020

Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery disease.

Martin R Cowie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.